Maddy summaryThe ATTAIN Mental Health Act requires the U.S. Department of Health and Human Services to create a public online dashboard that makes federal mental health and substance use disorder grant information easier to find. The dashboard will list grant names, show current application status (open, closed, or awarded), and provide direct links to apply, while being accessible under the Americans with Disabilities Act. It will help schools, health providers, tribal organizations, community groups, and other potential applicants quickly locate funding opportunities by location and program type. The dashboard must be updated regularly to reflect current grant openings and be designed with input from diverse stakeholders like hospitals and tribal entities.
Sponsored bills
Maddy summaryThis bill (S 2405) requires Medicare Part D prescription drug plans to ensure seniors can access most covered drugs at any network pharmacy starting in 2026, unless a drug qualifies as a "limited access drug" (e.g., requiring special handling or FDA restrictions). Plans must document why a drug is designated "limited access," report details like dispensing channels to the government annually, and share this information with pharmacies upon request. It also mandates an annual report to Congress on how plans use "limited access" designations and their impact on senior access. The law directly affects Medicare beneficiaries, drug plans, and pharmacies participating in Medicare Part D.
Maddy summaryThis bill expands Medicare coverage for obesity treatment. It allows more healthcare providers - including nurse practitioners, dietitians, and clinical psychologists - to offer intensive behavioral therapy for obesity, with requirements for coordination with primary care physicians. It also adds Medicare Part D coverage for FDA-approved medications used to treat obesity or manage weight in adults with related health conditions (like diabetes or high blood pressure). These changes directly affect Medicare beneficiaries with obesity, aiming to improve access to proven treatment options. The bill requires annual reports to Congress on implementation progress.
Maddy summaryS 2423, the ADS for Mental Health Services Act, requires major digital advertising platforms (those with over 100 million monthly users) to annually report on public service advertisements promoting mental, behavioral, or physical health resources. Specifically, platforms must disclose the number and value of free ads focused on local or regional health services, including those addressing suicide prevention, addiction, or social isolation. The Federal Trade Commission will collect these reports and submit annual summaries to Congress, aiming to track how platforms support public health messaging. This law directly affects large social media and search platforms but does not mandate new services or funding.
Maddy summaryS 2450 improves coordination between the Department of Energy (DOE) and National Science Foundation (NSF) for the National Quantum Initiative Program. It requires a dedicated liaison between DOE and NSF to align efforts and prevent duplication, while specifying that quantum research must cover key technologies like gate-based computing, qubits, and critical enabling tools (e.g., lasers, cryogenics). The bill also establishes a Manufacturing USA institute to develop scalable quantum manufacturing capabilities, workforce training, and secure supply chains for quantum components. These changes directly affect DOE, NSF, quantum researchers, and manufacturers working on quantum computing, sensing, and communication systems.
Maddy summaryThe CHANGE Act of 2023 requires Medicare to include standardized cognitive impairment screening during annual wellness visits and initial preventive physical exams for beneficiaries starting in 2024. It mandates that doctors use National Institute on Aging-approved tools to detect early signs of dementia, documenting results in patient records. This directly affects Medicare beneficiaries (primarily seniors), healthcare providers, and the Medicare system by integrating routine dementia screening into standard preventive care. The bill aims to improve early diagnosis, enabling timely care planning and access to support services, as highlighted by findings showing Alzheimer's affects 6.7 million Americans and costs $345 billion annually.
Maddy summaryThe WATCH Act requires foreign laboratories receiving U.S. federal funds for animal research to undergo quarterly inspections to ensure compliance with U.S. animal welfare standards. It directly affects overseas labs conducting NIH-funded studies involving animals, mandating regular checks of their animal care committees, treatment reviews, and record-keeping. Labs must maintain certification of compliance, with public access to these certificates, and face potential suspension of funding if they fail to correct violations after a warning. The bill establishes a process for U.S. authorities to coordinate inspections with foreign governments while upholding U.S. research standards.
Maddy summaryS 2372, the Accelerating Kids’ Access to Care Act, streamlines enrollment for out-of-state healthcare providers who treat Medicaid-eligible children under 21 with medically complex conditions. It requires states to adopt a process allowing these providers to join state Medicaid/CHIP programs without extra state-level screening, provided they already meet federal Medicare or home-state program requirements and pose low fraud risk. The bill establishes a 5-year enrollment period for eligible providers, directly affecting children needing specialized care across state lines and the providers serving them. Key provisions remove barriers to interstate care coordination while maintaining federal oversight standards.
Maddy summaryS 2368, the Global Investment in American Jobs Act of 2023, requires the U.S. Commerce Secretary to conduct a comprehensive review of how the United States attracts foreign direct investment from "responsible private-sector entities" in "trusted countries" (non-adversary nations). The review examines barriers like data localization, intellectual property protections, and supply chain dependencies, while assessing impacts on U.S. jobs, security, and competitiveness in advanced technology sectors. It specifically evaluates investments from entities not tied to "foreign adversaries" (like China) and analyzes how other countries screen state-backed investments. The bill mandates a public comment process and a report to Congress within one year, focusing on policy recommendations to strengthen U.S. competitiveness without compromising security or domestic workforce protections. This is a procedural bill setting up a review, not a new policy or funding measure.
Maddy summaryThe MAPS Act requires the U.S. Department of Health and Human Services (HHS) to create a database tracking essential medicines and their supply chains, focusing on drugs critical for public health emergencies or shortages. It mandates mapping production locations for key drug ingredients, finished products, and related materials across pharmaceutical manufacturers, with updates to be published by HHS. The bill also requires HHS to submit annual reports to Congress on progress, data gaps, and industry cooperation, while ensuring the database remains confidential and non-public. This primarily affects pharmaceutical manufacturers providing supply chain data and federal agencies coordinating on national security and health security threats.